5WS-25832-86340
4 vaccinations
3 coded responses
39 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 060 / CT
- Registered
- 2020-12-18
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Registered dependents
EHJ-13743-17101
Child or adolescent in my care · Female · 2022-10-30
Timeline
-
2020-12-18
Registered in v-safe
-
2020-12-18
Dose 1 — Pfizer-BioNTech
-
2020-12-18
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-28
- 2021-01-01
-
2021-01-08
Dose 2 — Pfizer-BioNTech
- 2021-01-15
- 2021-01-22
- 2021-01-29
- 2021-02-05
- 2021-02-12
- 2021-02-19
- 2021-04-09
- 2021-07-10
-
2021-09-24
Dose 3 — Pfizer-BioNTech
-
2021-09-29
Survey response — days 1–6 daily, dose 3MedDRA: Insomnia — Feeling: Good · Fatigue or tirednessFree text: InsomniaMedDRA releases: 2024-11 · check-in free text available
-
2021-09-30
Health check-in — days 1–6 daily, dose 3Feeling: Good · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-10-03
- 2021-10-08
- 2021-10-15
- 2021-10-22
- 2021-10-29
- 2021-11-05
- 2021-12-24
-
2022-03-25
Survey response — 6 months, dose 3MedDRA: Pregnancy — Feeling: FairFree text: PregnantMedDRA releases: 2024-11 · check-in free text available
- 2022-09-24
-
2022-10-29
Dose 4 — Pfizer-BioNTech
-
2022-10-30
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2022-10-31
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Fatigue or tiredness, NauseaAdult check-in
- 2022-11-02
-
2022-11-03
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Fatigue or tiredness, NauseaAdult check-in
-
2022-11-04
Health check-in — days 1–6 daily, dose 4Feeling: Good · Fatigue or tiredness, NauseaAdult check-in
- 2022-11-05
- 2022-11-14
- 2022-11-19
- 2022-11-26
- 2022-12-03
- 2022-12-10
- 2023-01-30
-
2023-04-29
Survey response — 6 months, dose 4MedDRA: Hidradenitis — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-04-29
Report sent to call center — 6 months, dose 4Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-05-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | |
| 2 | 2021-01-08 | Pfizer-BioNTech | |
| 3 | 2021-09-24 | Pfizer-BioNTech | No |
| 4 | 2022-10-29 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-04-29 | Unsuccessful |
Free text
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Insomnia
Release 11 — 6 months, dose 3
Symptoms: Pregnant
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Hidradenitis | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SRO | Insomnia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release